Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Lomitapide Mesylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 202914-84-9, Bms 201038-04, Lomitapide (mesylate), Aegr-733 mesylate, Bms-201038-04, Lomitapide mesilate
    Molecular Formula
    C40H41F6N3O5S
    Molecular Weight
    789.8  g/mol
    InChI Key
    QKVKOFVWUHNEBX-UHFFFAOYSA-N
    FDA UNII
    X4S83CP54E
    Lomitapide Mesylate is a methanesulfonic acid form of lomitapide, a small molecule inhibitor of microsomal triglyceride transfer protein.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    methanesulfonic acid;N-(2,2,2-trifluoroethyl)-9-[4-[4-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]piperidin-1-yl]butyl]fluorene-9-carboxamide
    2.1.2 InChI
    InChI=1S/C39H37F6N3O2.CH4O3S/c40-38(41,42)25-46-36(50)37(33-13-5-3-10-30(33)31-11-4-6-14-34(31)37)21-7-8-22-48-23-19-28(20-24-48)47-35(49)32-12-2-1-9-29(32)26-15-17-27(18-16-26)39(43,44)45;1-5(2,3)4/h1-6,9-18,28H,7-8,19-25H2,(H,46,50)(H,47,49);1H3,(H,2,3,4)
    2.1.3 InChI Key
    QKVKOFVWUHNEBX-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CS(=O)(=O)O.C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F
    2.2 Other Identifiers
    2.2.1 UNII
    X4S83CP54E
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 202914-84-9

    2. Bms 201038-04

    3. Lomitapide (mesylate)

    4. Aegr-733 Mesylate

    5. Bms-201038-04

    6. Lomitapide Mesilate

    7. Lomitapide Mesylate [usan]

    8. Aegr-733 Mesilate

    9. X4s83cp54e

    10. Chebi:72299

    11. 202914-84-9 (mesylate)

    12. N-(2,2,2-trifluoroethyl)-9-(4-(4-(4'-(trifluoromethyl)biphenyl-2-ylcarboxamido)piperidin-1-yl)butyl)-9h-fluorene-9-carboxamide Methanesulfonate

    13. Lomitapide Mesilate (jan)

    14. Lomitapide Mesylate (usan)

    15. N-(2,2,2-trifluoroethyl)-9-(4-(4-(4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamido)piperidin-1-yl)butyl)-9h-fluorene-9-carboxamide Methanesulfonate

    16. Lomitapide Mesilate [jan]

    17. 9h-fluorene-9-carboxamide, N-(2,2,2-trifluoroethyl)-9-(4-(4-(((4'-(trifluoromethyl)(1,1'-biphenyl)-2-yl)carbonyl)amino)-1-piperidinyl)butyl)-, Methanesulfonate

    18. Methanesulfonic Acid;n-(2,2,2-trifluoroethyl)-9-[4-[4-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]piperidin-1-yl]butyl]fluorene-9-carboxamide

    19. Unii-x4s83cp54e

    20. Juxtapid (tn)

    21. N-(2,2,2-trifluoroethyl)-9-(4-(4-(((4'-(trifluoromethyl)biphenyl-2-yl)carbonyl)amino)piperidin-1-yl)butyl)-9h-fluorene-9-carboxamide Methanesulfonate

    22. N-(2,2,2-trifluoroethyl)-9-{4-(4-({(4'-(trifluoromethyl)biphenyl-2-yl)carbonyl}amino)piperidin-1-yl)butyl}-9h-fluorene-9-carboxamide Methanesulfonate

    23. N-(2,2,2-trifluoroethyl)-9-{4-[4-({[4'-(trifluoromethyl)biphenyl-2-yl]carbonyl}amino)piperidin-1-yl]butyl}-9h-fluorene-9-carboxamide Methanesulfonate

    24. Lojuxta (tn)

    25. Lomitapide Monomesylate

    26. Lomitapide Methanesulfonate

    27. Bms-201038 Mesylate

    28. Schembl2731380

    29. Chembl2105662

    30. Dtxsid60174170

    31. Ex-a502

    32. Bms-201038ma

    33. Glxc-25701

    34. Amy38734

    35. Bcp10696

    36. Cia91484

    37. Lomitapide Mesilate [who-dd]

    38. Mfcd19443682

    39. S7633

    40. Akos025149431

    41. Ccg-270481

    42. Cs-3424

    43. Lomitapide Mesylate [orange Book]

    44. Ac-33863

    45. As-56518

    46. Da-33433

    47. Hy-14668

    48. Ft-0700260

    49. D09638

    50. J-690260

    51. Q27139887

    52. 1-(4-{9-[(2,2,2-trifluoroethyl)carbamoyl]-9h-fluoren-9-yl}butyl)-4-({[4'-(trifluoromethyl)biphenyl-2-yl]carbonyl}amino)piperidinium Methanesulfonate

    53. 2059395-52-5

    54. 9h-fluorene-9-carboxamide, N-(2,2,2-trifluoroethyl)-9-(4-(4-(((4'-(trifluoromethyl)(1,1'-biphenyl)-2-yl)carbonyl)amino)-1-piperidinyl)butyl)-, Methanesulphonate

    55. Aegr-733 Mesylate;bms-201038 Mesylate;aegr733 Mesylate;bms201038 Mesylate;aegr 733 Mesylate;bms 201038 Mesylate

    56. N-(2,2,2-trifluoroethyl)-9-(4-(4-(((4'-(trifluoromethyl)biphenyl-2-yl)carbonyl)amino)piperidin-1-yl)butyl)-9h-fluorene-9-carboxamide Methanesulphonate

    57. N-(2,2,2-trifluoroethyl)-9-[4-(4-{2-[4-(trifluoromethyl)phenyl]benzamido}piperidin-1-yl)butyl]-9h-fluorene-9-carboxamide; Methanesulfonic Acid

    2.4 Create Date
    2006-10-26
    3 Chemical and Physical Properties
    Molecular Weight 789.8 g/mol
    Molecular Formula C40H41F6N3O5S
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count12
    Rotatable Bond Count10
    Exact Mass789.26711156 g/mol
    Monoisotopic Mass789.26711156 g/mol
    Topological Polar Surface Area124 Ų
    Heavy Atom Count55
    Formal Charge0
    Complexity1200
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameJuxtapid
    PubMed HealthLomitapide (By mouth)
    Drug ClassesAntihyperlipidemic
    Drug LabelJUXTAPID capsules contain lomitapide mesylate, a synthetic lipid-lowering agent for oral administration.The chemical name of lomitapide mesylate is N-(2,2,2-trifluoroethyl)-9-[4-[4-[[[4'-(trifluoromethyl)[1,1'-biphenyl]-2-yl]carbonyl]amino]-1-pi
    Active IngredientLomitapide mesylate
    Dosage FormCapsule
    RouteOral
    Strengtheq 5mg base; eq 20mg base; eq 10mg base
    Market StatusPrescription
    CompanyAegerion

    2 of 2  
    Drug NameJuxtapid
    PubMed HealthLomitapide (By mouth)
    Drug ClassesAntihyperlipidemic
    Drug LabelJUXTAPID capsules contain lomitapide mesylate, a synthetic lipid-lowering agent for oral administration.The chemical name of lomitapide mesylate is N-(2,2,2-trifluoroethyl)-9-[4-[4-[[[4'-(trifluoromethyl)[1,1'-biphenyl]-2-yl]carbonyl]amino]-1-pi
    Active IngredientLomitapide mesylate
    Dosage FormCapsule
    RouteOral
    Strengtheq 5mg base; eq 20mg base; eq 10mg base
    Market StatusPrescription
    CompanyAegerion

    5 Pharmacology and Biochemistry
    5.1 FDA Pharmacological Classification
    5.1.1 Pharmacological Classes
    Microsomal Triglyceride Transfer Protein Inhibitor [EPC]; Microsomal Triglyceride Transfer Protein Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]